Medicare spending on opioids has grown in the last decade, raising concerns about fraud and drug abuse, an inspector general has found.
Spending for Medicare Part D, the program’s prescription drug benefit, has risen by more than $10 billion annually between 2006 and 2015, the Department of Health and Human Services inspector general found in a new report.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.